Medimmune
  • ABOUT MEDIMMUNE
    • Key Facts & Figures
    • Products
    • Facilities
    • At the Forefront
  • OUR CULTURE
    • History & Highlights
    • Visionaries at MedImmune
    • Executive Team
    • Corporate Responsibility
  • R & D
    • Pipeline
    • Drug Phase Chart
    • Biologics
    • Technologies & Approaches
    • Partnering
  • VENTURES
  • PRESS ROOM
  • CAREERS
  • CONTACT
  • Home >
    • News & Media

News and Media

For press releases:

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

Receive E-mail alerts

Subscribe to RSS feeds

December 22, 2000
MedImmune Announces Expanded Licensure of Manufacturing Facility
December 8, 2000
MedImmune Announces Executive Promotions
November 20, 2000
Outcomes Data for MedImmune's Synagis® Affirm
November 15, 2000
MGI Pharma Purchasing Hexalen® from MedImmune for Ovarian Cancer
October 30, 2000
New Data Demonstrate MedImmune's Synagis® Reduces RSV Hospitalization Rates and Costs for High-Risk Infants
October 18, 2000
MedImmune Net Earnings More than Double in 2000 Third Quarter
October 4, 2000
ALZA Corporation and Medimmune Announce Publication of Pivotal Ethyol® Data in Journal of Clinical Oncology
September 18, 2000
MedImmune Provides Update on Recently Presented Clinical Data
September 18, 2000
MedImmune Announces Executive Appointments and Promotions
August 21, 2000
MedImmune to Make CEO Transition Effective October 1, 2000
July 19, 2000
MedImmune Reports Second Quarter 2000 Results
July 19, 2000
MedImmune Grants SmithKline Beecham an Exclusive Worldwide License to Streptococcus Pneumoniae Vaccine Technology
June 13, 2000
MedImmune and Alkermes Sign Agreement to Develop Pulmonary Delivery System for Monoclonal Antibody Against Respiratory Syncytial Virus
June 13, 2000
MedImmune and Medarex Enter Broad Antibody Agreement
June 6, 2000
MedImmune to Promote David Mott to Chief Executive Officer; Wayne Hockmeyer ro Continue as Chairman of the Board
May 18, 2000
MedImmune Shareholders Clear the Way for Three-for-One Stock Split
April 19, 2000
MedImmune Net Earnings Grow 126 Percent in First Quarter
February 17, 2000
MedImmune’s Board of Directors Authorizes
January 26, 2000
MedImmune Sets New Revenue and Earnings Records
  • Terms and Conditions
  • |
  • Privacy Policy
  • |
  • Site Map
  • |
  • Contact Us
  • |
  • Glossary
Copyright © 2011 MedImmune, LLC. All rights reserved.